Shareholders' equity · 2017–2025
Legend Biotech shareholders' equity
$1.0B−3.7% · FY2025
Legend Biotech (LEGN) reported $1.0B in shareholders' equity for fiscal 2025, −3.7% year on year.
| Fiscal year | Shareholders' equity | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $1.0B | −3.7% | Open → |
| FY20242024-12-31 | $1.0B | −16.8% | Open → |
| FY20232023-12-31 | $1.3B | +68.1% | Open → |
| FY20222022-12-31 | $744M | −2.8% | Open → |
| FY20212021-12-31 | $766M | +28.1% | Open → |
| FY20202020-12-31 | $598M | +295.0% | Open → |
| FY20192019-12-31 | $151M | −40.2% | Open → |
| FY20182018-12-31 | $253M | +1,978.8% | Open → |
| FY20172017-12-31 | $12.2M | — | Open → |
Shareholders' equity — Shareholders' equity is what remains after subtracting liabilities from assets — the accounting book value of the company, not its market value.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2017–2025 compound annual growth +73.6%
Figures are reported under IFRS, in US dollars.
Shareholders' equity at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Legend Biotech shareholders' equity |url=https://companiesranked.com/en/company/legend-biotech/shareholders-equity |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Legend Biotech shareholders' equity. CompaniesRanked. https://companiesranked.com/en/company/legend-biotech/shareholders-equityBibTeX
@misc{companiesranked-en-company-legend-biotech-shareholders-equity-2026,
author = {{CompaniesRanked}},
title = {{Legend Biotech shareholders' equity}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/legend-biotech/shareholders-equity}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 20-F · 0001801198-26-000008 · March 10, 2026
{{cite web |title=Legend Biotech shareholders' equity — 20-F (0001801198-26-000008) |url=https://www.sec.gov/Archives/edgar/data/1801198/000180119826000008/legn-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-03-10}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.